Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
EUCTR |
Last refreshed on:
|
19 March 2012 |
Main ID: |
EUCTR2004-001467-22-IT |
Date of registration:
|
13/04/2005 |
Prospective Registration:
|
No |
Primary sponsor: |
|
Public title:
|
A PHASE 2 EFFICACY AND SAFETY STUDY OF SU011248 IN PATIENTS WITH METASTATIC NON-SMALL CELL LUNG CANCER
|
Scientific title:
|
A PHASE 2 EFFICACY AND SAFETY STUDY OF SU011248 IN PATIENTS WITH METASTATIC NON-SMALL CELL LUNG CANCER |
Date of first enrolment:
|
12/03/2005 |
Target sample size:
|
60 |
Recruitment status: |
Not Recruiting |
URL:
|
https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2004-001467-22 |
Study type:
|
Interventional clinical trial of medicinal product |
Study design:
|
Controlled: no
Randomised: no
Open:
Single blind:
Double blind:
Parallel group:
Cross over:
Other:
If controlled, specify comparator, Other Medicinial Product:
Placebo:
Other:
|
Phase:
|
|
|
Countries of recruitment
|
Italy
|
Spain
| | | | | | |
Contacts
|
Name:
|
|
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
|
|
Name:
|
|
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
|
| |
Key inclusion & exclusion criteria
|
Inclusion criteria: Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range
Exclusion criteria:
Age minimum:
Age maximum:
Gender:
Female: yes Male: yes
|
Health Condition(s) or Problem(s) studied
|
Metastatic non-small cell lung cancer MedDRA version: 6.1
Level: PT
Classification code 10059515
|
Intervention(s)
|
Product Name: SU011248 Product Code: NA Pharmaceutical Form: Capsule, hard INN or Proposed INN: SU011248 CAS Number: NA Current Sponsor code: NA Concentration unit: mg milligram(s) Concentration type: equal Concentration number: 12.5-
|
Primary Outcome(s)
|
Main Objective:
|
Primary end point(s):
|
Secondary Objective:
|
Secondary ID(s)
|
2004-001467-22-ES
|
A6181040
|
Source(s) of Monetary Support
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|